Yiwei Li - Publications

Affiliations: 
2015-2019 University of Oxford, Oxford, United Kingdom 

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li Y, Hu J, Wang Z, Yang K, Huang W, Cao B, Li Z, Zhang W, Pan F. Low-Temperature Catalytic Graphitization to Enhance Na-Ion Transportation in Carbon Electrodes. Acs Applied Materials & Interfaces. PMID 31250632 DOI: 10.1021/acsami.9b07206  0.76
2019 Li Y, Guo F, Hao Y, Gupta SK, Hu J, Wang Y, Wang N, Zhao Y, Guo M. Helical nanofiber yarn enabling highly stretchable engineered microtissue. Proceedings of the National Academy of Sciences of the United States of America. PMID 31019088 DOI: 10.1073/pnas.1821617116  0.68
2019 Si W, Ye S, Ren Z, Liu X, Wu Z, Li Y, Zhou J, Zhang S, Li Y, Deng R, Chen D. miR‑335 promotes stress granule formation to inhibit apoptosis by targeting ROCK2 in acute ischemic stroke. International Journal of Molecular Medicine. PMID 30747210 DOI: 10.3892/ijmm.2019.4073  0.76
2019 Li Q, Huang L, Ma N, Li Z, Han Y, Wu L, Zhang X, Li Y, Zhang H. Relationship between left ventricular vortex and preejectional flow velocity during isovolumic contraction studied by using vector flow mapping. Echocardiography (Mount Kisco, N.Y.). PMID 30726568 DOI: 10.1111/echo.14277  0.68
2018 Chen P, Yan S, Wang J, Guo Y, Dong Y, Feng X, Zeng X, Li Y, Du W, Liu BF. Dynamic Microfluidic Cytometry for Single-Cell Cellomics: High-throughput Probing Single-Cell-Resolution Signaling. Analytical Chemistry. PMID 30561989 DOI: 10.1021/acs.analchem.8b05179  0.68
2018 Huang W, Hu J, Yang L, Zhao W, Wang Z, Wang H, Guo Z, Li Y, Liu J, Yang K, Pan F. Revealing the degradation mechanism of LiMnFePO by single particle electrochemistry method. Acs Applied Materials & Interfaces. PMID 30516367 DOI: 10.1021/acsami.8b18930  0.68
2018 Gupta SK, Li Y, Guo M. Anisotropic mechanics and dynamics of a living mammalian cytoplasm. Soft Matter. PMID 30488938 DOI: 10.1039/c8sm01708e  0.36
2018 Chen C, Wang M, Wu J, Fu H, Yang H, Tian Z, Tu T, Peng H, Sun Y, Xu X, Jiang J, Schröter NBM, Li Y, Pei D, Liu S, et al. Electronic structures and unusually robust bandgap in an ultrahigh-mobility layered oxide semiconductor, BiOSe. Science Advances. 4: eaat8355. PMID 30225369 DOI: 10.1126/sciadv.aat8355  0.6
2018 Liu X, Xu Q, Mei L, Lei H, Wen Q, Miao J, Huang H, Chen D, Du S, Zhang S, Zhou J, Deng R, Li Y, Li C, Li H. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats. International Immunopharmacology. 61: 169-177. PMID 29883962 DOI: 10.1016/j.intimp.2018.05.032  0.68
2018 Xu Q, Liu X, Mei L, Wen Q, Chen J, Miao J, Lei H, Huang H, Chen D, Du S, Liu A, Zhang S, Zhou J, Deng R, Li Y, et al. Paeonol Reduces the Nucleocytoplasmic Transportation of HMGB1 by Upregulating HDAC3 in LPS-Induced RAW264.7 Cells. Inflammation. PMID 29736733 DOI: 10.1007/s10753-018-0800-0  0.68
2018 Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". Cancer Letters. 423: 153. PMID 29606293 DOI: 10.1016/j.canlet.2018.03.020  0.68
2017 Azmi AS, Li Y, Muqbil I, Aboukameel A, Senapedis W, Baloglu E, Landesman Y, Shacham S, Kauffman MG, Philip PA, Mohammad RM. Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration. Oncotarget. 8: 82144-82155. PMID 29137251 DOI: 10.18632/oncotarget.19285  0.68
2017 Wang Y, Hu Y, Zeng Z, Li Y, Su H, Li Y, Wang R, Zhang M, Yang Y, Deng J. Influence of androgen on myocardial apoptosis and expression of myocardial IR and IRS‑1 in chronic heart failure rat models. Molecular Medicine Reports. PMID 29115626 DOI: 10.3892/mmr.2017.8018  0.68
2017 Yan S, Chen P, Zeng X, Zhang X, Li Y, Xia Y, Dai X, Wang J, Feng X, Du W, Liu BF. Integrated Multifunctional Electrochemistry Microchip for Highly Efficient Capture, Release, Lysis and Analysis of Circulating Tumor Cells. Analytical Chemistry. PMID 29072078 DOI: 10.1021/acs.analchem.7b02469  0.68
2017 Liu Y, Li Y, Ren Z, Si W, Li Y, Wei G, Zhao W, Zhou J, Tian Y, Chen D. MicroRNA-125a-3p is involved in early behavioral disorders in stroke-afflicted rats through the regulation of Cadm2. International Journal of Molecular Medicine. PMID 29039453 DOI: 10.3892/ijmm.2017.3179  0.68
2017 Jin W, Li Q, Luo X, Zhong J, Song Y, Li Y. Da-Cheng-Qi Decoction Combined with Conventional Treatment for Treating Postsurgical Gastrointestinal Dysfunction. Evidence-Based Complementary and Alternative Medicine : Ecam. 2017: 1987396. PMID 28928788 DOI: 10.1155/2017/1987396  0.68
2017 Zhao H, Ding R, Zhao X, Li Y, Qu L, Pei H, Yildirimer L, Wu Z, Zhang W. Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering. Drug Discovery Today. PMID 28869820 DOI: 10.1016/j.drudis.2017.04.002  0.76
2017 Chen P, Guo Y, Feng X, Yan S, Wang J, Li Y, Du W, Liu BF. A microfluidic chemical function generator for probing dynamic cell signaling. Analytical Chemistry. PMID 28791865 DOI: 10.1021/acs.analchem.7b01967  0.68
2017 Azmi AS, Li Y, Muqbil I, Aboukameel A, Senapedis W, Baloglu E, Landesman Y, Shacham S, Kauffman MG, Philip PA, Mohammad RM. Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration. Oncotarget. PMID 28753564 DOI: 10.18632/oncotarget.19285  0.68
2017 Mohammad RM, Li Y, Muqbil I, Aboukameel A, Senapedis W, Baloglu E, Landesman Y, Philip PA, Azmi AS. Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation. Small Gtpases. 0. PMID 28641032 DOI: 10.1080/21541248.2017.1329694  0.68
2017 Wu H, Zhao X, Li Y, Zhao R. Reconsideration of the primary and secondary diagnostic criteria of Meckel's diverticulum scintigraphy. A study of 93 confirmed cases. Hellenic Journal of Nuclear Medicine. PMID 28315903 DOI: 10.1967/s002449910501  0.76
2017 Wu H, Huang Z, Ji M, Li Y, Zhao R. Detection of an Infant's Duodenal Atresia by Milk Scan. Clinical Nuclear Medicine. 42: 140-142. PMID 28060781 DOI: 10.1097/RLU.0000000000001524  0.6
2016 Kong X, Li M, Xue S, Hartley W, Chen C, Wu C, Li X, Li Y. Acid transformation of bauxite residue: Conversion of its alkaline characteristics. Journal of Hazardous Materials. PMID 27838072 DOI: 10.1016/j.jhazmat.2016.10.073  0.4
2016 Xiao F, Zheng Z, Zhang H, Xin Z, Chen Y, Li Y. Who Are You More Likely to Help? The Effects of Expected Outcomes and Regulatory Focus on Prosocial Performance. Plos One. 11: e0165717. PMID 27824909 DOI: 10.1371/journal.pone.0165717  0.72
2016 Zhu F, Huang N, Xue S, Hartley W, Li Y, Zou Q. Effects of binding materials on microaggregate size distribution in bauxite residues. Environmental Science and Pollution Research International. PMID 27628703 DOI: 10.1007/s11356-016-7626-9  0.36
2016 Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. PMID 27412558 DOI: 10.1007/s10549-016-3904-y  0.68
2016 He T, Yao S, Zhang J, Li Y, Li X, Hu J, Chen R, Lin X. Strong multiphoton absorption properties of one styrylpyridinium salt in a highly polar solvent. Optics Express. 24: 11091-11102. PMID 27409932  0.64
2016 Li Y, Chen P, Wang Y, Yan S, Feng X, Du W, Koehler SA, Demirci U, Liu BF. Rapid Assembly of Heterogeneous 3D Cell Microenvironments in a Microgel Array. Advanced Materials (Deerfield Beach, Fla.). PMID 26991071 DOI: 10.1002/adma.201600247  0.44
2016 Li Y, Sarkar FH. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer. International Journal of Biological Sciences. 12: 326-37. PMID 26929739 DOI: 10.7150/ijbs.15017  0.68
2016 Wu J, Ye Z, Li X, Wang X, Luo F, Sheng B, Li Y, Lyu J. Optimization of a NH4PF6-enhanced, non-organic solvent, dual microextraction method for determination of phthalate metabolites in urine by high performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1014: 1-9. PMID 26852090 DOI: 10.1016/j.jchromb.2016.01.024  0.36
2016 Ahmad A, Li Y, Sarkar FH. The bounty of nature for changing the cancer landscape. Molecular Nutrition & Food Research. PMID 26799714 DOI: 10.1002/mnfr.201500867  0.68
2016 Liu C, Li Y, Li Y, Chen P, Feng X, Du W, Liu BF. Rapid three-dimensional microfluidic mixer for high viscosity solutions to unravel earlier folding kinetics of G-quadruplex under molecular crowding conditions. Talanta. 149: 237-43. PMID 26717836 DOI: 10.1016/j.talanta.2015.11.036  0.68
2015 Zhuo C, Liang L, Ying M, Li Q, Li D, Li Y, Peng J, Huang L, Cai S, Li X. Laparoscopic Low Anterior Resection and Eversion Technique Combined With a Nondog Ear Anastomosis for Mid- and Distal Rectal Neoplasms: A Preliminary and Feasibility Study. Medicine. 94: e2285. PMID 26683958 DOI: 10.1097/MD.0000000000002285  0.4
2015 Li Y, Sarkar FH. Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. PMID 26501150 DOI: 10.1159/000439307  0.68
2015 Wei G, Huang Y, Li F, Zeng F, Li Y, Deng R, Lai Y, Zhou J, Huang G, Chen D. XingNaoJing, prescription of traditional Chinese medicine, prevents autophagy in experimental stroke by repressing p53-DRAM pathway. Bmc Complementary and Alternative Medicine. 15: 377. PMID 26481508 DOI: 10.1186/s12906-015-0882-2  0.44
2015 Farooqi AA, Li Y, Sarkar FH. The biological complexity of RKIP signaling in human cancers. Experimental & Molecular Medicine. 47: e185. PMID 26403261 DOI: 10.1038/emm.2015.70  0.68
2015 Chen Y, Li Y, Ma Y, Meng Q, Yan Y, Shi J. A Nicotinamide Adenine Dinucleotide Dispersed Multi-walled Carbon Nanotubes Electrode for Direct and Selective Electrochemical Detection of Uric Acid. Analytical Sciences : the International Journal of the Japan Society For Analytical Chemistry. 31: 799-803. PMID 26256604 DOI: 10.2116/analsci.31.799  0.72
2015 Zhuo C, Li Q, Wu Y, Li Y, Nie J, Li D, Peng J, Lian P, Li B, Cai G, Li X, Cai S. LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer. Oncotarget. PMID 26172297 DOI: 10.18632/oncotarget.4450  0.4
2015 Li Y, Feng X, Wang Y, Du W, Chen P, Liu C, Liu BF. Assembly of multiple cell gradients directed by three-dimensional microfluidic channels. Lab On a Chip. PMID 26126652 DOI: 10.1039/c5lc00618j  0.68
2015 Ahmad A, Ginnebaugh KR, Li Y, Padhye SB, Sarkar FH. Molecular targets of naturopathy in cancer research: bridge to modern medicine. Nutrients. 7: 321-34. PMID 25569626 DOI: 10.3390/nu7010321  0.68
2015 Zhang C, Li Y, Xue X, Chu P, Liu C, Yang K, Jiang Y, Chen WQ, Zou G, Liang XJ. A smart pH-switchable luminescent hydrogel. Chemical Communications (Cambridge, England). 51: 4168-71. PMID 25564289 DOI: 10.1039/c4cc09861g  0.68
2015 Qin F, Zhang K, Zhang L, Li J, Lu H, Lai Y, Zhang Z, Zhou Y, Li Y, Fang J. Sustainable synthetic route for γ-Fe2O3/C hybrid as anode material for lithium-ion batteries. Dalton Transactions (Cambridge, England : 2003). 44: 2150-6. PMID 25510410 DOI: 10.1039/c4dt03278k  0.52
2015 Li Y, Go VL, Sarkar FH. The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas. 44: 1-10. PMID 25493373 DOI: 10.1097/MPA.0000000000000257  0.68
2015 Kong D, Sethi S, Li Y, Chen W, Sakr WA, Heath E, Sarkar FH. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes. The Prostate. 75: 161-74. PMID 25307492 DOI: 10.1002/pros.22901  0.68
2014 Zhang C, Xue X, Luo Q, Li Y, Yang K, Zhuang X, Jiang Y, Zhang J, Liu J, Zou G, Liang XJ. Self-assembled Peptide nanofibers designed as biological enzymes for catalyzing ester hydrolysis. Acs Nano. 8: 11715-23. PMID 25375351 DOI: 10.1021/nn5051344  0.44
2014 Li Y, Yan X, Feng X, Wang J, Du W, Wang Y, Chen P, Xiong L, Liu BF. Agarose-based microfluidic device for point-of-care concentration and detection of pathogen. Analytical Chemistry. 86: 10653-9. PMID 25264815 DOI: 10.1021/ac5026623  0.68
2014 Wang H, Zeng X, Chang X, Peng X, Xia L, Li Y. [Determination of thiourea dioxide in lotus seed paste fillings by solid phase extraction-liquid chromatography-tandem mass spectrometry]. SE Pu = Chinese Journal of Chromatography / Zhongguo Hua Xue Hui. 32: 21-5. PMID 24783864  0.4
2014 Bao B, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Aboukameel A, Mohammad R, Van Buren E, Azmi AS, Sarkar FH. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer. Stem Cells and Development. 23: 1947-58. PMID 24734907 DOI: 10.1089/scd.2013.0551  0.44
2014 Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. The Journal of Biological Chemistry. 289: 14520-33. PMID 24719318 DOI: 10.1074/jbc.M113.532887  0.68
2014 Li Y, Ahmad A, Kong D, Bao B, Sarkar FH. Recent progress on nutraceutical research in prostate cancer. Cancer Metastasis Reviews. 33: 629-40. PMID 24375392 DOI: 10.1007/s10555-013-9478-9  0.68
2014 Ahmad A, Li Y, Bao B, Kong D, Sarkar FH. Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Molecular Nutrition & Food Research. 58: 79-86. PMID 24272883 DOI: 10.1002/mnfr.201300528  0.68
2014 Guo Y, Li Y, Ito N. Exploring the predicted effect of social networking site use on perceived social capital and psychological well-being of Chinese international students in Japan. Cyberpsychology, Behavior and Social Networking. 17: 52-8. PMID 23971431 DOI: 10.1089/cyber.2012.0537  0.6
2014 Bao B, Azmi AS, Li Y, Ahmad A, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness. Current Stem Cell Research & Therapy. 9: 22-35. PMID 23957937  0.68
2013 Sarkar S, Dubaybo H, Ali S, Goncalves P, Kollepara SL, Sethi S, Philip PA, Li Y. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. American Journal of Cancer Research. 3: 465-77. PMID 24224124  0.68
2013 Ahmad A, Maitah MY, Ginnebaugh KR, Li Y, Bao B, Gadgeel SM, Sarkar FH. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. Journal of Hematology & Oncology. 6: 77. PMID 24199791 DOI: 10.1186/1756-8722-6-77  0.68
2013 Li Y, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting MicroRNAs for personalized cancer therapy. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 22: 415-7. PMID 23948699 DOI: 10.1159/000353562  0.68
2013 Sethi S, Li Y, Sarkar FH. Regulating miRNA by natural agents as a new strategy for cancer treatment. Current Drug Targets. 14: 1167-74. PMID 23834152  0.68
2013 Ahmad A, Biersack B, Li Y, Bao B, Kong D, Ali S, Banerjee S, Sarkar FH. Perspectives on the role of isoflavones in prostate cancer. The Aaps Journal. 15: 991-1000. PMID 23824838 DOI: 10.1208/s12248-013-9507-1  0.68
2013 Li Y, Feng X, Du W, Li Y, Liu BF. Ultrahigh-throughput approach for analyzing single-cell genomic damage with an agarose-based microfluidic comet array. Analytical Chemistry. 85: 4066-73. PMID 23477638 DOI: 10.1021/ac4000893  0.44
2013 Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? Antioxidants & Redox Signaling. 19: 139-50. PMID 23391445 DOI: 10.1089/ars.2013.5233  0.68
2013 Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anti-Cancer Agents in Medicinal Chemistry. 13: 1014-24. PMID 23272911  0.68
2013 Ahmad A, Biersack B, Li Y, Kong D, Bao B, Schobert R, Padhye SB, Sarkar FH. Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 13: 1002-13. PMID 23272910  0.68
2013 Wang Z, Ali S, Banerjee S, Bao B, Li Y, Azmi AS, Korc M, Sarkar FH. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. Journal of Cellular Physiology. 228: 556-62. PMID 22806240 DOI: 10.1002/jcp.24162  0.68
2013 Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Letters. 338: 94-100. PMID 22445908 DOI: 10.1016/j.canlet.2012.03.018  0.68
2012 Bao B, Ali S, Ahmad A, Azmi AS, Li Y, Banerjee S, Kong D, Sethi S, Aboukameel A, Padhye SB, Sarkar FH. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment. Plos One. 7: e50165. PMID 23272057 DOI: 10.1371/journal.pone.0050165  0.68
2012 Kashat M, Azzouz L, Sarkar SH, Kong D, Li Y, Sarkar FH. Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. American Journal of Translational Research. 4: 432-42. PMID 23145211  0.68
2012 Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSC-related miRNAs for cancer therapy by natural agents. Current Drug Targets. 13: 1858-68. PMID 23140295  0.68
2012 Kong D, Ahmad A, Bao B, Li Y, Banerjee S, Sarkar FH. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. Plos One. 7: e45045. PMID 23024790 DOI: 10.1371/journal.pone.0045045  0.68
2012 Ahmad A, Sarkar SH, Aboukameel A, Ali S, Biersack B, Seibt S, Li Y, Bao B, Kong D, Banerjee S, Schobert R, Padhye SB, Sarkar FH. Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. Carcinogenesis. 33: 2450-6. PMID 22971573 DOI: 10.1093/carcin/bgs290  0.68
2012 Bao B, Ahmad A, Kong D, Ali S, Azmi AS, Li Y, Banerjee S, Padhye S, Sarkar FH. Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. Plos One. 7: e43726. PMID 22952749 DOI: 10.1371/journal.pone.0043726  0.68
2012 Bao B, Ahmad A, Li Y, Azmi AS, Ali S, Banerjee S, Kong D, Sarkar FH. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Expert Opinion On Therapeutic Targets. 16: 1041-54. PMID 22877147 DOI: 10.1517/14728222.2012.714774  0.68
2012 Ahmad A, Sarkar SH, Bitar B, Ali S, Aboukameel A, Sethi S, Li Y, Bao B, Kong D, Banerjee S, Padhye SB, Sarkar FH. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Molecular Cancer Therapeutics. 11: 2193-201. PMID 22821148 DOI: 10.1158/1535-7163.MCT-12-0232-T  0.68
2012 Li Y, Kong D, Ahmad A, Bao B, Dyson G, Sarkar FH. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics. 7: 940-9. PMID 22805767 DOI: 10.4161/epi.21236  0.68
2012 Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochimica Et Biophysica Acta. 1826: 272-96. PMID 22579961 DOI: 10.1016/j.bbcan.2012.04.008  0.68
2012 Du S, Li H, Cui Y, Yang L, Wu J, Huang H, Chen Y, Huang W, Zhang R, Yang J, Chen D, Li Y, Zhang S, Zhou J, Wei Z, et al. Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway. International Immunopharmacology. 13: 331-40. PMID 22561446 DOI: 10.1016/j.intimp.2012.03.011  0.44
2012 Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, et al. Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM. Plos One. 7: e33729. PMID 22442719 DOI: 10.1371/journal.pone.0033729  0.68
2012 Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis. Plos One. 7: e33011. PMID 22412975 DOI: 10.1371/journal.pone.0033011  0.68
2012 Kong D, Heath E, Chen W, Cher M, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, et al. Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. American Journal of Translational Research. 4: 14-23. PMID 22347519  0.68
2012 Li Y, Maitah MY, Ahmad A, Kong D, Bao B, Sarkar FH. Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opinion On Therapeutic Targets. 16: 49-66. PMID 22243133 DOI: 10.1517/14728222.2011.617367  0.68
2012 Bao B, Thakur A, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Ali S, Lum LG, Sarkar FH. The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. Biochimica Et Biophysica Acta. 1825: 160-72. PMID 22155217 DOI: 10.1016/j.bbcan.2011.11.002  0.68
2012 Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, Sarkar FH. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Research. 72: 335-45. PMID 22108826 DOI: 10.1158/0008-5472.CAN-11-2182  0.68
2012 Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 5: 355-64. PMID 22086681 DOI: 10.1158/1940-6207.CAPR-11-0299  0.68
2011 Li Y, Kong D, Bao B, Ahmad A, Sarkar FH. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients. 3: 877-96. PMID 22200028 DOI: 10.3390/nu3100877  0.68
2011 Stock NS, Bain G, Zunic J, Li Y, Ziff J, Roppe J, Santini A, Darlington J, Prodanovich P, King CD, Baccei C, Lee C, Rong H, Chapman C, Broadhead A, et al. 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor. Journal of Medicinal Chemistry. 54: 8013-29. PMID 22059882 DOI: 10.1021/jm2008369  0.44
2011 Li Y, Kong D, Wang Z, Ahmad A, Bao B, Padhye S, Sarkar FH. Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 4: 1495-506. PMID 21680704 DOI: 10.1158/1940-6207.CAPR-11-0077  0.68
2011 Wang Z, Banerjee S, Ahmad A, Li Y, Azmi AS, Gunn JR, Kong D, Bao B, Ali S, Gao J, Mohammad RM, Miele L, Korc M, Sarkar FH. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways. Plos One. 6: e20537. PMID 21673986 DOI: 10.1371/journal.pone.0020537  0.68
2011 Kong D, Li Y, Wang Z, Sarkar FH. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers. 3: 716-29. PMID 21643534 DOI: 10.3390/cancers30100716  0.68
2011 Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Anticancer Research. 31: 1105-13. PMID 21508353  0.44
2011 Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. Journal of Cellular Biochemistry. 112: 2296-306. PMID 21503965 DOI: 10.1002/jcb.23150  0.68
2011 Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Letters. 307: 26-36. PMID 21463919 DOI: 10.1016/j.canlet.2011.03.012  0.68
2011 Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 135-46. PMID 21129444 DOI: 10.1016/j.bbcan.2010.11.003  0.68
2011 Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Sarkar FH. Pancreatic cancer: understanding and overcoming chemoresistance. Nature Reviews. Gastroenterology & Hepatology. 8: 27-33. PMID 21102532 DOI: 10.1038/nrgastro.2010.188  0.68
2011 Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. Journal of Cellular Biochemistry. 112: 78-88. PMID 20658545 DOI: 10.1002/jcb.22770  0.68
2010 Li Y, VandenBoom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. Cancer Research. 70: 5703. PMID 25242818 DOI: 10.1158/1538-7445.AM10-5703  0.68
2010 Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. Plos One. 5: e12445. PMID 20805998 DOI: 10.1371/journal.pone.0012445  0.68
2010 Sarkar FH, Li Y, Wang Z, Kong D. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Reviews. 29: 383-94. PMID 20711635 DOI: 10.1007/s10555-010-9233-4  0.68
2010 Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 109-18. PMID 20692200 DOI: 10.1016/j.drup.2010.07.001  0.68
2010 Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica Et Biophysica Acta. 1806: 258-67. PMID 20600632 DOI: 10.1016/j.bbcan.2010.06.001  0.68
2010 Sarkar FH, Li Y, Wang Z, Kong D. Novel targets for prostate cancer chemoprevention. Endocrine-Related Cancer. 17: R195-212. PMID 20576802 DOI: 10.1677/ERC-10-0074  0.68
2010 Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Current Protein & Peptide Science. 11: 398-408. PMID 20491628  0.68
2010 Wang Z, Ahmad A, Li Y, Kong D, Azmi AS, Banerjee S, Sarkar FH. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochimica Et Biophysica Acta. 1806: 122-30. PMID 20434526 DOI: 10.1016/j.bbcan.2010.04.003  0.68
2010 Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, Li Y, Sarkar FH. FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharmaceutical Research. 27: 1159-68. PMID 20354770 DOI: 10.1007/s11095-010-0106-x  0.68
2010 Sarkar FH, Li Y, Wang Z, Padhye S. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Current Pharmaceutical Design. 16: 1801-12. PMID 20345353  0.68
2010 Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharmaceutical Research. 27: 1027-41. PMID 20306121 DOI: 10.1007/s11095-010-0105-y  0.68
2010 Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 13: 57-66. PMID 20236855 DOI: 10.1016/j.drup.2010.02.001  0.68
2010 Li Y, Vandenboom TG, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research. 70: 1486-95. PMID 20124483 DOI: 10.1158/0008-5472.CAN-09-2792  0.68
2010 Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Journal of Cellular Biochemistry. 109: 726-36. PMID 20052673 DOI: 10.1002/jcb.22451  0.68
2010 Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Current Drug Targets. 11: 745-51. PMID 20041844  0.68
2010 Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treatment Reviews. 36: 151-6. PMID 20022709 DOI: 10.1016/j.ctrv.2009.11.006  0.68
2010 Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Letters. 292: 141-8. PMID 20022691 DOI: 10.1016/j.canlet.2009.11.012  0.68
2010 Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. Current Stem Cell Research & Therapy. 5: 74-80. PMID 19951255  0.68
2010 Stock N, Baccei C, Bain G, Broadhead A, Chapman C, Darlington J, King C, Lee C, Li Y, Lorrain DS, Prodanovich P, Rong H, Santini A, Zunic J, Evans JF, et al. 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor. Bioorganic & Medicinal Chemistry Letters. 20: 213-7. PMID 19914828 DOI: 10.1016/j.bmcl.2009.10.131  0.44
2010 Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, Ali R, Sarkar FH. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Research and Treatment. 122: 337-46. PMID 19813088 DOI: 10.1007/s10549-009-0572-1  0.68
2009 Lorrain DS, Bain G, Correa LD, Chapman C, Broadhead AR, Santini AM, Prodanovich P, Darlington JV, Hutchinson JH, King C, Lee C, Baccei C, Li Y, Arruda JM, Evans JF. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation. The Journal of Pharmacology and Experimental Therapeutics. 331: 1042-50. PMID 19749079 DOI: 10.1124/jpet.109.158089  0.44
2009 Hutchinson JH, Li Y, Arruda JM, Baccei C, Bain G, Chapman C, Correa L, Darlington J, King CD, Lee C, Lorrain D, Prodanovich P, Rong H, Santini A, Stock N, et al. 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103). Journal of Medicinal Chemistry. 52: 5803-15. PMID 19739647 DOI: 10.1021/jm900945d  0.44
2009 Sarkar FH, Li Y. Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treatment Reviews. 35: 597-607. PMID 19660870 DOI: 10.1016/j.ctrv.2009.07.001  0.68
2009 Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Research. 69: 6704-12. PMID 19654291 DOI: 10.1158/0008-5472.CAN-09-1298  0.68
2009 Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells (Dayton, Ohio). 27: 1712-21. PMID 19544444 DOI: 10.1002/stem.101  0.68
2009 Li H, Du S, Yang L, Chen Y, Huang W, Zhang R, Cui Y, Yang J, Chen D, Li Y, Zhang S, Zhou J, Wei Z, Yao Z. Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen. Innate Immunity. 15: 143-54. PMID 19474208 DOI: 10.1177/1753425908101509  0.72
2008 Vandenboom Ii TG, Li Y, Philip PA, Sarkar FH. MicroRNA and Cancer: Tiny Molecules with Major Implications. Current Genomics. 9: 97-109. PMID 19440450 DOI: 10.2174/138920208784139555  0.68
2002 Chen Y, Zhang P, Li Y, Zhuang J, Gao L. Clinicopathologic significance of structural alterations of p53 protein in papillary thyroid carcinoma. Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 31: 217-21. PMID 12475438  0.72
Show low-probability matches.